D-181

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameD-181
Drug Alias NameD-181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 1 antagonistsTubulin modulatorsPlatelet-derived growth factor receptor beta inhibitors +[6] 
TargetsStem cell growth factor receptorPlatelet-derived growth factor receptor betaFibroblast growth factor receptor 1 +[6] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of SciencesEast China University Of Science And Technology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A